Menu Search
Equities

Streamline Health Solutions Inc

LV10:DEU

Streamline Health Solutions Inc

Actions
  • Price (EUR)2.12
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-52.36%
  • Beta--
Data delayed at least 15 minutes, as of Oct 03 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The Company sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. It offers an array of professional services, including system implementation.

  • Revenue in USD (TTM)20.30m
  • Net income in USD-18.82m
  • Incorporated1996
  • Employees77.00
  • Location
    Streamline Health Solutions Inc2400 Old Milton Parkway, Box 1353ALPHARETTA 30009United StatesUSA
  • Phone+1 (404) 446-2051
  • Fax+1 (302) 674-5266
  • Websitehttps://www.streamlinehealth.net/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.